Under Pressure: Arugula Extract's Effect on Blood Pressure in Hypertensive Individuals

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source

ClinicalTrials.gov

Source record ID

NCT07904832

Title field or adapter rule

{'original_value': "Under Pressure: Arugula Extract's Effect on Blood Pressure in Hypertensive Individuals", 'source_field': 'protocolSection.identificationModule.officialTitle'}

Ingested At

2026-10-31T23:27:31.779742+00:00

Published At

2026-10-29T00:00:00+00:00

Record Updated At

2026-10-29

Source Retrieved At

2026-10-31T22:18:32.315169+00:00

Timestamp Basis

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Date limitation

ClinicalTrials.gov API/RSS response retrieval timestamp recorded by Dossier adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions

["Hypertension (HTN)", "Hypertension"]

protocolSection.statusModule.lastUpdatePostDateStruct

{"date": "2026-10-29", "type": "ACTUAL"}

protocolSection.identificationModule.nctId

"NCT07904832"

protocolSection.identificationModule.officialTitle

"Under Pressure: Arugula Extract\u0027s Effect on Blood Pressure in Hypertensive Individuals"

protocolSection.statusModule.overallStatus

"COMPLETED"

protocolSection.designModule.phases

["NA"]

protocolSection.statusModule.resultsFirstPostDateStruct

null

Study condition terms

• Hypertension (HTN) (protocolSection.conditionsModule.conditions)
• Hypertension (protocolSection.conditionsModule.conditions)

Interventions recorded in this study

• {'armGroupLabels': ['Arugula Extract Followed by Placebo'], 'description': 'Participants consume a single oral dose of 4,000 mg arugula extract (AE), providing approximately 400 mg of dietary nitrate (10% nitrate concentration). Arugula Extract is administered in capsule form following baseline cardiovascular and vascular assessments. Blood pressure, heart rate, and blood biomarkers are assessed at baseline, 1, 2, 3, and 24 hours following supplementation. Flow-mediated dilation is assessed at baseline, 3 hours, and 24 hours.', 'name': 'Arugula Extract', 'type': 'DIETARY_SUPPLEMENT'} (protocolSection.armsInterventionsModule.interventions[])
• {'armGroupLabels': ['Placebo Followed by Arugula Extract'], 'description': 'Participants consume a single oral dose of 4,000 mg psyllium husk as the placebo condition. The placebo is administered in capsule form following baseline cardiovascular and vascular assessments. Blood pressure, heart rate, and blood biomarkers are assessed at baseline, 1, 2, 3, and 24 hours following supplementation. Flow-mediated dilation is assessed at baseline, 3 hours, and 24 hours.', 'name': 'Psyllium Husk', 'type': 'DIETARY_SUPPLEMENT'} (protocolSection.armsInterventionsModule.interventions[])

An intervention appearing in a study record does not establish an effect or an approved use.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.